Syndrome News and Research

RSS
SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Study identifies new regions of positive selection in SARS-CoV-2

Study identifies new regions of positive selection in SARS-CoV-2

Researchers try and pop SARS-CoV-2 with an AFM tip - virion surprisingly resilient

Researchers try and pop SARS-CoV-2 with an AFM tip - virion surprisingly resilient

Large mother-child paired study promises more answers on COVID-19 in pregnancy

Large mother-child paired study promises more answers on COVID-19 in pregnancy

Novel tool uses fat to diagnose musculoskeletal disease and predict falls, fractures

Novel tool uses fat to diagnose musculoskeletal disease and predict falls, fractures

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Combination of two mosquito-borne viruses may be a trigger for stroke

Combination of two mosquito-borne viruses may be a trigger for stroke

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Study invalidates Ebselen and other broad-spectrum SARS-CoV-2 Mpro inhibitors

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Animal data supports efficacy of baricitinib vs SARS-COV-2

Animal data supports efficacy of baricitinib vs SARS-COV-2

T cells on the front line of COVID-19 response

T cells on the front line of COVID-19 response

Biomarker predicts disease severity in COVID-19 patients

Biomarker predicts disease severity in COVID-19 patients

Wearing eyeglasses protects against SARS-CoV-2

Wearing eyeglasses protects against SARS-CoV-2

New drug candidate suppresses SARS-CoV-2 replication

New drug candidate suppresses SARS-CoV-2 replication

Flexibility of glycosylated membrane-bound ACE2 suggests mechanical energy source in opening of SARS-CoV-2 spike

Flexibility of glycosylated membrane-bound ACE2 suggests mechanical energy source in opening of SARS-CoV-2 spike